ARCHIVES

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Review Groups Merged Into One Umbrella Group

November 17, 1995

Arizona Cancer Center Seeks NCI Recognition As Comprehensive

May 29, 1987

Sloan-Kettering Cited For 8 Violations Of NY State Standards

November 24, 1995

Move Starts To Strip Anticancer Drug Regulation From FDA After New Charges It Is Delaying INDs

October 15, 1976

Protocols Approved By NCI During January 2004

February 27, 2004

In Brief: Ireland Cancer Center Named Comprehensive; UPCI Appoints Four Program Directors

February 27, 1998